75.29
price up icon0.87%   0.65
pre-market  Vorhandelsmarkt:  75.15   -0.14   -0.19%
loading
Schlusskurs vom Vortag:
$74.64
Offen:
$74.69
24-Stunden-Volumen:
4.14M
Relative Volume:
0.96
Marktkapitalisierung:
$44.20B
Einnahmen:
$5.69B
Nettoeinkommen (Verlust:
$1.41B
KGV:
10.78
EPS:
6.9828
Netto-Cashflow:
$577.90M
1W Leistung:
+3.21%
1M Leistung:
+1.18%
6M Leistung:
+5.26%
1J Leistung:
+7.14%
1-Tages-Spanne:
Value
$74.43
$75.57
1-Wochen-Bereich:
Value
$72.40
$75.57
52-Wochen-Spanne:
Value
$64.89
$83.00

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
Firmenname
Edwards Lifesciences Corp
Name
Telefon
(949) 250-2500
Name
Adresse
ONE EDWARDS WAY, IRVINE, CA
Name
Mitarbeiter
15,800
Name
Twitter
@edwardslifesci
Name
Nächster Verdiensttermin
2025-02-11
Name
Neueste SEC-Einreichungen
Name
EW's Discussions on Twitter

Vergleichen Sie EW mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
EW
Edwards Lifesciences Corp
75.29 43.82B 5.69B 1.41B 577.90M 6.9828
Medical Devices icon
ABT
Abbott Laboratories
129.51 223.72B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
100.53 147.05B 18.49B 2.50B 3.49B 1.6801
Medical Devices icon
SYK
Stryker Corp
381.22 143.14B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
95.92 122.86B 34.20B 4.69B 5.30B 3.6218

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-08 Herabstufung Oppenheimer Outperform → Perform
2025-10-07 Hochstufung Evercore ISI In-line → Outperform
2025-07-29 Hochstufung BTIG Research Neutral → Buy
2025-04-24 Hochstufung Piper Sandler Neutral → Overweight
2025-01-30 Hochstufung Stifel Hold → Buy
2025-01-16 Herabstufung Wolfe Research Peer Perform → Underperform
2024-12-16 Hochstufung BofA Securities Neutral → Buy
2024-10-11 Fortgesetzt Morgan Stanley Equal-Weight
2024-09-18 Herabstufung Jefferies Buy → Hold
2024-07-31 Hochstufung Daiwa Securities Neutral → Outperform
2024-07-29 Hochstufung Wolfe Research Underperform → Peer Perform
2024-07-25 Herabstufung BofA Securities Buy → Neutral
2024-07-25 Herabstufung JP Morgan Overweight → Neutral
2024-07-25 Herabstufung Robert W. Baird Outperform → Neutral
2024-07-25 Herabstufung TD Cowen Buy → Hold
2024-07-25 Herabstufung Truist Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2024-05-22 Hochstufung Citigroup Neutral → Buy
2024-05-14 Hochstufung Deutsche Bank Hold → Buy
2024-03-07 Hochstufung BofA Securities Neutral → Buy
2024-02-02 Hochstufung Wells Fargo Equal Weight → Overweight
2024-01-04 Herabstufung Evercore ISI Outperform → In-line
2023-12-11 Herabstufung Citigroup Buy → Neutral
2023-11-28 Herabstufung Wolfe Research Peer Perform → Underperform
2023-09-26 Hochstufung Oppenheimer Perform → Outperform
2023-07-19 Eingeleitet Robert W. Baird Outperform
2023-05-30 Fortgesetzt Morgan Stanley Overweight
2023-03-29 Eingeleitet UBS Neutral
2023-03-08 Herabstufung Wells Fargo Overweight → Equal Weight
2023-02-06 Herabstufung Raymond James Outperform → Mkt Perform
2023-01-31 Herabstufung Bernstein Outperform → Underperform
2023-01-30 Herabstufung Piper Sandler Overweight → Neutral
2022-12-06 Herabstufung Stifel Buy → Hold
2022-10-28 Herabstufung Oppenheimer Outperform → Perform
2022-10-26 Eingeleitet Mizuho Buy
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-29 Herabstufung Canaccord Genuity Buy → Hold
2022-04-13 Eingeleitet Truist Buy
2022-04-06 Eingeleitet Wolfe Research Outperform
2022-03-16 Hochstufung Bernstein Mkt Perform → Outperform
2022-03-02 Fortgesetzt BofA Securities Neutral
2022-02-02 Hochstufung UBS Neutral → Buy
2022-01-27 Bestätigt Citigroup Buy
2022-01-27 Bestätigt Evercore ISI Outperform
2022-01-27 Bestätigt Raymond James Outperform
2022-01-27 Bestätigt Stifel Buy
2022-01-27 Bestätigt UBS Neutral
2021-12-17 Hochstufung JP Morgan Neutral → Overweight
2021-12-15 Hochstufung Citigroup Neutral → Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-12-06 Hochstufung Wells Fargo Equal Weight → Overweight
2021-07-30 Bestätigt Canaccord Genuity Buy
2021-07-30 Bestätigt Deutsche Bank Hold
2021-07-30 Bestätigt Jefferies Buy
2021-07-30 Bestätigt Morgan Stanley Overweight
2021-07-30 Bestätigt Oppenheimer Outperform
2021-07-30 Bestätigt Stifel Buy
2021-07-30 Bestätigt UBS Neutral
2021-07-30 Bestätigt Wells Fargo Equal Weight
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Neutral
2021-04-05 Hochstufung Evercore ISI In-line → Outperform
2020-12-16 Herabstufung Citigroup Buy → Neutral
2020-12-11 Bestätigt Canaccord Genuity Buy
2020-09-11 Eingeleitet Wolfe Research Underperform
2020-04-28 Herabstufung Wells Fargo Overweight → Equal Weight
2020-04-17 Hochstufung SVB Leerink Mkt Perform → Outperform
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Neutral
2020-01-10 Eingeleitet Oppenheimer Outperform
2020-01-02 Herabstufung Evercore ISI Outperform → In-line
2019-10-24 Bestätigt Canaccord Genuity Buy
2019-09-23 Eingeleitet Piper Jaffray Overweight
2019-07-24 Bestätigt BofA/Merrill Buy
2019-03-18 Bestätigt Canaccord Genuity Buy
2019-01-18 Hochstufung BofA/Merrill Neutral → Buy
2019-01-03 Eingeleitet Deutsche Bank Hold
2018-11-28 Eingeleitet UBS Neutral
2018-10-16 Eingeleitet Barclays Underweight
2018-10-02 Herabstufung BofA/Merrill Buy → Neutral
2018-10-02 Herabstufung Guggenheim Buy → Neutral
Alle ansehen

Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten

pulisher
06:33 AM

Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results - Yahoo

06:33 AM
pulisher
06:27 AM

Is Edwards Lifesciences Corporation (EWL) stock resilient in recession scenariosJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com

06:27 AM
pulisher
04:23 AM

Quantitative breakdown of Edwards Lifesciences Corporation recent moveJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com

04:23 AM
pulisher
03:46 AM

How Edwards Lifesciences Corporation stock reacts to new regulationsQuarterly Profit Summary & High Conviction Buy Zone Picks - newser.com

03:46 AM
pulisher
Oct 20, 2025

How Edwards Lifesciences Corporation (EWL) stock responds to bond marketRecession Risk & Low Risk Entry Point Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Using portfolio simulators with Edwards Lifesciences Corporation includedJuly 2025 Fed Impact & Stepwise Trade Signal Guides - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Edwards Lifesciences Corporation stock cheap by valuation metricsTrend Reversal & Safe Entry Momentum Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Edwards Lifesciences Corporation stock prediction for this week2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Edwards Lifesciences Corporation stock survive global slowdownWeekly Trend Recap & Verified Stock Trade Ideas - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Why Edwards Lifesciences Corporation stock remains on buy listsJuly 2025 Outlook & Verified Swing Trading Watchlists - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Edwards Lifesciences Corporation stock return to pre crisis levelsTake Profit & Safe Swing Trade Setups - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Published on: 2025-10-18 04:03:36 - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Gains Report: Is Edwards Lifesciences Corporation stock supported by strong cash flowsTrend Reversal & Free Expert Approved Momentum Trade Ideas - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Edwards Lifesciences (EW) Added to Evercore ISI's Tactical Outpe - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and Edwards Lifesciences (EW) - The Globe and Mail

Oct 17, 2025
pulisher
Oct 16, 2025

Using Python tools to backtest Edwards Lifesciences Corporation strategiesQuarterly Earnings Summary & Real-Time Volume Analysis - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW - GlobeNewswire Inc.

Oct 15, 2025
pulisher
Oct 15, 2025

How high can Edwards Lifesciences Corporation stock goIndex Update & Proven Capital Preservation Methods - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Is Edwards Lifesciences Corporation stock a good choice for value investorsVolume Spike & Community Verified Swing Trade Signals - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Leerink Partners Adjusts Price Target on Edwards Lifesciences to $84 From $85, Maintains Market Perform Rating - MarketScreener

Oct 14, 2025
pulisher
Oct 14, 2025

Mizuho Adjusts Price Target on Edwards Lifesciences to $90 From $95, Maintains Outperform Rating - MarketScreener

Oct 14, 2025
pulisher
Oct 13, 2025

Oversold Conditions For Edwards Lifesciences (EW) - Nasdaq

Oct 13, 2025
pulisher
Oct 13, 2025

What is the fair value of Edwards Lifesciences Corporation stock nowWeekly Market Outlook & Target Return Focused Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Aberdeen Group plc Increases Position in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

OFI Invest Asset Management Has $26.57 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Stonehage Fleming Financial Services Holdings Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Callan Family Office LLC Boosts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 12, 2025
pulisher
Oct 11, 2025

EW Investor News: Rosen Law Firm Investigates Breaches of - GlobeNewswire

Oct 11, 2025
pulisher
Oct 10, 2025

Real time breakdown of Edwards Lifesciences Corporation stock performanceGDP Growth & Weekly Market Pulse Updates - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Ranking Edwards Lifesciences Corporation among high performing stocks via toolsPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Blair William & Co. IL Has $30.51 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What machine learning models say about Edwards Lifesciences CorporationWeekly Trade Report & Weekly Breakout Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Visual trend scoring systems applied to Edwards Lifesciences Corporation2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Vontobel Holding Ltd. Reduces Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Edwards Lifesciences (NYSE:EW) Given "Hold (C)" Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Here's What to Expect From Edwards Lifesciences’ Next Earnings Report - MSN

Oct 09, 2025
pulisher
Oct 08, 2025

Edwards Lifesciences Leads Healthcare Stocks in S&P 500 - Kalkine Media

Oct 08, 2025
pulisher
Oct 08, 2025

Edwards Lifesciences' Long-Term Plan Raises Concerns Amid 'Structural' Risks, Oppenheimer Says - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Edwards Lifesciences (NYSE:EW) Upgraded at Evercore ISI - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Edwards Lifesciences stock downgraded by Oppenheimer on structural concerns - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Oppenheimer Downgrades Edwards Lifesciences to Market Perform From Outperform - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Edwards Lifesciences Corporation $EW Shares Bought by Mirova US LLC - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Shell Asset Management Co. Acquires 19,014 Shares of Edwards Lifesciences Corporation $EW - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Edwards Lifesciences (EW) Upgraded by Evercore ISI - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

Edwards Lifesciences (EW) Receives Analyst Upgrade and Price Tar - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

Edwards Lifesciences stock maintains Overweight rating ahead of PARTNER 3 data - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Evercore ISI Upgrades Edwards Lifesciences to Outperform From In Line, Adjusts PT to $88 From $80 - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

Seamount Financial Group Inc. Invests $259,000 in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 07, 2025

Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$75.48
price up icon 1.93%
medical_devices PHG
$28.47
price down icon 0.18%
$68.43
price up icon 2.75%
medical_devices STE
$242.22
price up icon 0.84%
$326.85
price up icon 2.59%
Kapitalisierung:     |  Volumen (24h):